Page 5 - 2019年9月第30卷第18期

Meta-analysis of Therapeutic Efficacy and Safety of Mirtazapine Combined with Selective Calcium Channel Blocker in the
Treatment of Irritable Bowel Syndrome …………………………………………………………………………………………
………………………………………… CAI Linkun，PENG Zhuoyu，HUANG Shi，HUANG Yalan，TAO Lifen，LAN Siying（2563）
Study on the Effects of Treatment Compliance on Short-term Clinical Outcome among Community Patients with Type 2 Dia-
betes Mellitus in China ………………………………………………………… LI Hongchao，GUAN Haijing，LIU Guo’en（2570）

CHINA PHARMACY （Semimonthly）
Founded in January 1990
Vol.30，No.18，Sept. 2019
Total No.660 Published on Sept. 30，2019
Responsible Institution Phone
National Health Commission，P.R. China 86-23-63830521；86-23-63830907
Sponsored by E-mail
Chinese Hospital Association info@china-pharmacy.com
Chongqing Cancer Institute Website
Edited by http：//www.china-pharmacy.com
China Pharmacy Editorial and Publishing Center Online Submission
Director of Editorial Commission http：//2018.china-pharmacy.com
XUE Xiaolin Printed by
Editor-in-Chief Chongqing Guofeng Printing Co.，Ltd.
MA Jin Distributed by
Vice Editor-in-Chief China：Chongqing Post Offices（Code No.78-33）
HU Xin Overseas：China International Book Trading Corporation
Chief Editor （Code No.4703SM）
ZHANG Jian Subscription Rates
Exclusively Co-Sponsored by US $ 8.00 per issue；US $ 192.00 per annum
Qilu Pharmaceutical Group Co.，Ltd. CSSN ISSN 1001-0408
Published by CN 50-1055/R
China Pharmacy Editorial Department CODEN
Postal Address ZYHAA4
129 Daping Main Street，Yuzhong District，Chongqing Perennial Legal Counsel
400042，China Chongqing Hengze Law Firm